期刊文献+

阿替普酶联合优瑞克林治疗急性脑梗死的临床疗效及安全性分析 被引量:1

Analysis of Clinical Curative Effect and Safety of Alteplase and Urinary Kallidinogenase in Treatment of Acute Cerebral Infraction
下载PDF
导出
摘要 目的探讨阿替普酶联合优瑞克林治疗急性脑梗死的临床疗效及安全性。方法根据随机数字表法将方便选取的2015年1月—2018年2月200例急性脑梗死患者分成不同组。对照组给予阿替普酶治疗,观察组则给予阿替普酶联合优瑞克林治疗。比较两组急性脑梗死治疗效果;生命体征稳定时间、出院时间;治疗前后患者神经功能缺损程度;治疗副作用率。结果观察组急性脑梗死总有效率90例(90.00%)高于对照组70例(70.00%),(χ~2=13.520 0,P<0.05)。观察组生命体征稳定时间、出院时间(5.11±1.42)d、(12.13±0.24)d优于对照组(8.41±2.25)d、(15.23±1.51)d,(P<0.05);治疗后观察组神经功能缺损程度(10.33±1.20)分优于对照组(15.19±1.33)分,(t=8.233,P<0.05)。观察组治疗副作用率12例(12.00%)和对照组15例(15.00%)差异无统计学意义(χ~2=0.634,P>0.05)。结论阿替普酶联合优瑞克林治疗急性脑梗死的临床疗效及安全性高,可有效改善神经功能缺损程度和血流动力学情况,且无严重不良反应,安全有效,值得推广应用。 Objective To study the clinical curative effect and safety of alteplase and urinary kallidinogenase in treatment of acute cerebral infraction.Methods200cases of patients with acute cerebral infraction admitted and treated in our hospital from January2015to February2018were convenient selected and randomly divided into two groups,the control group were treated with alteplase,while the observation group were treated with alteplase and urinary kallidinogenase,and the treatment effect,steady time of vital signs,discharged time,nerve function defect degree before and after treatment and side effect rate were compared between the two groups.Results The treatment effect in the observation group was higher than that in the control group,90cases(90.00%) vs70cases(70.00%),(χ^2=13.5200,P<0.05),and the steady time of vital signs and discharged time in the observation group were better than those in the control group,[(5.11±1.42)d,(12.13±0.24)d vs(8.41±2.25)d,(15.23±1.51)d,P<0.05],after treatment,the nerve function defect degree in the observation group was better than that in the control group,[(10.33±1.20)points vs(15.19±1.33)points,t=8.233,P<0.05)],and the difference in the treatment side effect rate in the observation group and in the control group was not obvious,[12case(12.00%)vs15case(15.00%),χ^2=0.634,P>0.05].Conclusion The clinical curative effect and safety of alteplase and urinary kallidinogenase in treatment of acute cerebral infraction are high,which can effectively improve the nerve function defect degree and hemodynamics,without serious adverse reactions,and it is safe and effective,and it is worth promotion and application.
作者 郭芳 郑冲 GUO Fang;ZHENG Chong(Department of Neurology,Longyan First Hospital Affiliated to Fujian Medical University,Longyan,Fujian Province,364000 China)
出处 《中外医疗》 2018年第33期91-93,共3页 China & Foreign Medical Treatment
关键词 阿替普酶 优瑞克林 急性脑梗死 临床疗效 安全性 Alteplase Urinary kallidinogenase Acute cerebral infraction Clinical curative effect Safety
  • 相关文献

参考文献7

二级参考文献67

  • 1何燕玲.老年人日常生活活动功能的评定[J].老年医学,1990,10:266-268.
  • 2Leira E C, Coffey C S, Jorge R E, et al. The NIHSS supplementary motor scale: a valid tool for multidisciplinary recovery trials [J]. Cerebrovasc Dis, 2013, 36(1): 69- 73.
  • 3Astrup J, Siesj? B K, Symon L. Thresholds in cerebral ischemia-the ischemic penumbra [J]. Stroke, 1981, 12(6): 723-725.
  • 4RUSSEK NS, JENSEN MB. Histological quantification of brain tissue in-flammatory cell infiltration after focal cere- bral infarction: a systematic review [J]. lnt J Neurosci, 2014, 124(3):160-165.
  • 5GOUNIS MG, NOGUEIRA RG, MEHRA M, et al. A thromboembolic model for the efficacy and safety evalua- tion of combined mechanical and pharmacologic revascu- larization strategies [ J ]. J Neurointerv Surg, 2013, 5 ( 1 ): 85-89.
  • 6PARSONS M, SPRATT N, BIVARD A, et al. A random- ized trial of tenecte-plase versus alteplase for acute isch- emic stroke [J]. N Engl J Meal, 2012, 366( 12):1099-1107.
  • 7NAKAGAWARA J, MINEMATSU K, OKADA Y, et al. Thrombolysis with 0.6mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice, the Ja- pan post-marketing alteplase registration study (J-MARS) [J]. Stroke, 2010, 4(1):1984-1989.
  • 8蔡业峰,贾真,张新春,招远祺,王立新,郭建文,欧爱华,梁伟雄,裴建,黄燕,黄培新.美国国立卫生院卒中量表(NIHSS)中文版多中心测评研究--附537例缺血中风多中心多时点临床测评研究[J].北京中医药大学学报,2008,31(7):494-498. 被引量:441
  • 9袁平,周翔宇,周述芝,何延政.血栓性疾病患者外周血IL-6、IL-8、IL-10及TNF-α水平及意义探讨[J].中国临床医学,2009,16(1):20-21. 被引量:6
  • 10中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153. 被引量:3406

共引文献144

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部